Kstation
Saxenda Pen 6mg/mL (3mL x 1 Pen)
$110.00
Unit price perSaxenda Pen
6 mg/mL Pre-filled Injection Pen (3mL)
Product Overview
Active Ingredient & Mechanism
A glucagon-like peptide-1 (GLP-1) receptor agonist that is 97% similar to the naturally occurring hormone GLP-1. Works by acting on areas of the brain involved in appetite regulation, leading to reduced feelings of hunger and increased feelings of satiety.
How Saxenda Works
Appetite Regulation
Acts on brain receptors to reduce hunger signals and increase satiety, helping you feel fuller for longer periods.
Gastric Emptying Delay
Contributes to delayed gastric emptying, which helps maintain feelings of fullness and reduces food intake.
Expected Effects & Benefits
Weight Loss Support
Assists in chronic weight management when combined with a reduced-calorie diet and increased physical activity.
Appetite Control
Promotes weight loss by regulating appetite and caloric intake through natural hormone mimicking.
Long-term Maintenance
Helps maintain weight reduction in the long term when used as part of a comprehensive lifestyle program.
Metabolic Benefits
Supports healthy metabolic function through improved glucose regulation and insulin sensitivity.
Usage Instructions & Dose Escalation
Important Usage Notes
- If a dose is missed and more than 12 hours have passed, skip the missed dose and resume normal schedule the following day
- The dose escalation schedule is crucial to minimize gastrointestinal side effects
- Users must be trained on proper injection technique and dose-setting before first use
- Single-use needles are required for each injection (needles not included with pen)
Who Is Saxenda For?
Product Specifications & Storage Requirements
| Specification | Details | Purpose |
|---|---|---|
| Active Ingredient | Liraglutide 6 mg/mL | GLP-1 receptor agonist for appetite regulation |
| Pen Volume | 3 mL pre-filled pen | Multiple doses per pen (up to 30 days) |
| Dose Range | 0.6 mg to 3.0 mg daily | Flexible dosing with escalation protocol |
| Administration | Once daily subcutaneous injection | Convenient self-administration |
| Pen Design | Pre-filled, single-patient-use | Ready-to-use convenience and safety |
| Usage Period | 30 days after first use | Optimal potency and safety |
Storage Requirements
Unopened Pens
Store in refrigerator at 2°C to 8°C (36°F to 46°F) until expiration date. Do not freeze - discard any pen that has been frozen.
After First Use
Can be stored in refrigerator or at room temperature (15°C to 30°C / 59°F to 86°F) for up to 30 days. Must be discarded after 30 days even if solution remains.
Safety Information & Important Warnings
Emergency Response Protocol
Severe Adverse Reactions
Contact healthcare provider immediately if experiencing severe abdominal pain, persistent vomiting, or signs of allergic reaction including rash, swelling, or difficulty breathing.
Medical Support
Ensure 24/7 access to healthcare provider contact information. Report any unexpected symptoms or concerns during treatment period.
Precautions & Contraindications
Absolute Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Previous serious hypersensitivity reaction to liraglutide or any excipients
- Pregnancy and breastfeeding (not studied in these populations)
Special Populations Requiring Caution
Diabetic Patients
Monitor blood glucose closely, especially if taking insulin or sulfonylureas, as dose adjustments may be necessary to prevent hypoglycemia.
Kidney/Liver Impairment
Use with caution in patients with renal or hepatic impairment. Dose adjustment may be required based on severity of condition.
Elderly Patients
Limited experience in patients over 75 years. Start with lower doses and monitor more frequently for adverse effects.
Gallbladder Disease
May increase risk of gallbladder-related events. Monitor patients with history of gallstones or gallbladder disease.
Clinical Effectiveness & Research Data
Clinical Study Results
Weight Loss Efficacy
Clinical trials demonstrate significant weight loss when combined with lifestyle interventions compared to placebo plus lifestyle modifications.
Appetite Regulation
Proven reduction in hunger scores and increased satiety ratings in controlled clinical studies across diverse patient populations.
Safety Monitoring
Extensive safety database from clinical trials and post-marketing surveillance demonstrating manageable side effect profile.
Long-term Outcomes
Studies show sustained weight loss maintenance with continued treatment and lifestyle adherence over extended periods.
Professional Support & Monitoring Requirements
Healthcare Provider Responsibilities
Patient Assessment
Comprehensive medical history, BMI calculation, contraindication screening, and baseline laboratory evaluations before treatment initiation.
Training & Education
Proper injection technique instruction, dose escalation explanation, side effect management, and lifestyle counseling integration.
Regular Monitoring
Scheduled follow-up appointments for weight tracking, side effect assessment, dose optimization, and treatment plan adjustments.
Safety Surveillance
Ongoing monitoring for adverse events, drug interactions, and treatment effectiveness evaluation throughout therapy duration.
Patient Support Resources
Lifestyle Integration & Best Practices
Complementary Interventions
Reduced-Calorie Diet
Structured nutrition plan with appropriate caloric deficit, balanced macronutrients, and sustainable eating patterns for long-term success.
Increased Physical Activity
Progressive exercise program incorporating both cardiovascular and resistance training, tailored to individual fitness levels and capabilities.
Behavioral Modifications
Cognitive-behavioral strategies for eating habits, stress management, and lifestyle pattern changes to support sustained weight management.
Regular Monitoring
Consistent weight tracking, symptom logging, and progress evaluation to optimize treatment outcomes and identify areas for improvement.
Treatment Success Factors
- Adherence to daily injection schedule and dose escalation protocol
- Consistent implementation of dietary and exercise recommendations
- Regular healthcare provider follow-up and communication
- Realistic goal setting and expectation management
- Strong support system and behavioral change commitment
Treatment Timeline & What to Expect
Realistic Expectations
Individual Variation
Response rates and weight loss amounts vary significantly between individuals based on starting weight, lifestyle factors, and genetic predisposition.
Gradual Progress
Sustainable weight loss occurs gradually over months, not weeks. Patience and consistency with treatment and lifestyle modifications are essential.
